SCHEMBL21961817

SCHEMBL21961817

CC[C@H]1CC[C@@H](OC)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23114294 1.00 — —
SCHEMBL21946982 1.00 — —
SCHEMBL5888393 1.00 — —
SCHEMBL23133729 1.00 — —
SCHEMBL10290749 1.00 — —
SCHEMBL14396284 0.87 — —
SCHEMBL21947332 0.86 DPP4 (0.33) —
SCHEMBL17835259 0.86 DPP4 (0.33) —
SCHEMBL17858342 0.86 DPP4 (0.33) —
SCHEMBL257813 0.86 DPP4 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200131201-A1 TYK2 INHIBITORS AND USES THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2020-04-30 — — US disclosed
Send feedback